ArticleClinical and translational science2023

Model-informed approach to support pediatric dosing for the pan-PI3K inhibitor copanlisib in children and adolescents with relapsed/refractory solid tumors.

Peter N Morcos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.